Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. annual/quarterly long term debt history from 2010 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Charles River Laboratories International, Inc. long term debt for the quarter ending December 29, 2018 were 1.61B, a 48.27% increase year-over-year.
- Charles River Laboratories International, Inc. long term debt for 2018 were 1.61B, a 48.27% increase from 2017.
- Charles River Laboratories International, Inc. long term debt for 2017 were 1.09B, a 7.99% decrease from 2016.
- Charles River Laboratories International, Inc. long term debt for 2016 were 1.18B, a 44.98% increase from 2015.
- Charles River Laboratories International, Inc. long term debt for 2015 were 814.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Charles River Laboratories International, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $1,611 |
| 2017 | $1,086 |
| 2016 | $1,181 |
| 2015 | $814 |
| 2014 | $717 |
| 2013 | $663 |
| 2012 | $666 |
| 2011 | $718 |
| 2010 | $701 |
| Charles River Laboratories International, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2018-12-29 | $1,611 |
| 2017-12-30 | $1,086 |
| 2016-12-31 | $1,181 |
| 2015-12-26 | $814 |
| 2014-12-27 | $717 |
| 2013-12-28 | $663 |
| 2012-12-29 | $666 |
| 2011-12-31 | $718 |
| 2010-12-25 | $701 |
Charles River Laboratories International, Inc. Long Term Debt — FAQ
Charles River Laboratories International, Inc. (CRL) long term debt over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRL's long term debt history?
The chart and table above show Charles River Laboratories International, Inc.'s long term debt by year and by quarter, including the growth rate.